Pacira Reports Q1 2026 Earnings Results
Pacira (PCRX) reported Q1 2026 earnings with net sales of $143.3 million, up 7% year-over-year, driven by volume growth. The company also noted a 15% increase in ZILRETTA sales and a 21% rise in ioverao sales, though non-GAAP gross margin slightly declined to 80% from 81% in the prior year.
Tickers: $PCRX
Topics: earnings financial results profitability R&D spending revenue sales growth share repurchase